Inhalis is committed to improve patients’ life with safer and more effective treatment options. Solid science and industry-leading delivery technology are combined with an experienced management team to research and develop new inhaled treatments for IPF and other life-threatening diseases.
Location
-
Corso Elvezia 4, 6900 Lugano, Switzerland
Canton
Facts & figures
-
Type of organizationPrivate company
-
Year of foundation2023
-
Number of employees in Switzerland1-9
Core competencies
Keep browsing
You may also be interested in
Memorises Bio AG 
- R&D
Member
Pilatus Biosciences SA
- R&D
Member
Step Pharma SAS
- R&D
Member